# Restrictive Use of Dexamethasone in Glioblastoma

> **NCT04266977** · NA · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 50 (estimated)

## Conditions studied

- Glioblastoma
- Dexamethasone
- Steroids

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04266977
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-08
- **Primary completion:** 2027-04
- **Final completion:** 2028-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04266977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04266977, "Restrictive Use of Dexamethasone in Glioblastoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04266977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*